
Sign up to save your podcasts
Or


AstraZeneca’s vaccine gets UK approval, but the FDA has yet to decide. Bill Barker analyzes that story, reacts to 2021 precitions about the price of oil and a return to domestic travel, and shares why future investors might not realize how crazy 2020 was for the stock market.
By The Motley Fool4.7
16041,604 ratings
AstraZeneca’s vaccine gets UK approval, but the FDA has yet to decide. Bill Barker analyzes that story, reacts to 2021 precitions about the price of oil and a return to domestic travel, and shares why future investors might not realize how crazy 2020 was for the stock market.

3,212 Listeners

1,493 Listeners

806 Listeners

939 Listeners

521 Listeners

1,164 Listeners

2,178 Listeners

825 Listeners

1,404 Listeners

1,041 Listeners

9,628 Listeners

195 Listeners

816 Listeners

81 Listeners

568 Listeners

992 Listeners

51 Listeners